A study to investigate the pharmacokinetics, safety, and tolerability of AZD4144 in participants with severe renal impairment, end-stage kidney disease, and in healthy participants

Trial Identifier:	D9440C00003
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	November 2024
Primary Completion Date:	June 2025
Study Completion Date:	June 2025
Condition:	Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BG	Sofia, BG, 1612
RO	Bucuresti, RO, 010731

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.